NEW DELHI (Reuters) -India has invited bids for the privatisation of Indian Medicines Pharmaceutical Corporation, the government said on Thursday.
It plans to sells its 98.1% stake in the company that makes alternative medicines, according to a government document. The remaining 1.89%, held by Kumaon Mandal Vikas Nigam Ltd., a firm owned by the northern state of Uttarakhand, will also be offloaded through the transaction.
The government previously tried to sell Indian Medicines Pharmaceutical in 2019. Stake sales in other state-owned firms such as BEML and Shipping Corp of India, announced in 2019, have also been hit by several delays.
Interested buyers in Indian Medicines Pharmaceutical should submit initial bids to the government by Oct. 15, according to the government document.
The company has reported a 205% jump in profit after tax in 2021/22 to 337.6 million rupees ($4.08 million). Its revenue from operations rose to 2.6 billion rupees in 2021/22 from 1.6 billion rupees the previous year.
(Reporting by Nikunj Ohri; Editing by Sharon Singleton and Susan Fenton)
Also Read
With Adani, Agarwal under scrutiny, India's privatisation drive stalled
Govt panel may draft list of small public sector banks for privatisation
Contaminated drugs: USFDA uncovers failures in India's pharma factories
Medicines for anxiety, diabetes to get cheaper as NPPA fixes ceiling prices
Indian firm used toxic industrial-grade ingredient in cough syrups
Growth prospects bright, private investment has taken off: CEA Nageswaran
Investment growth comes up short despite govt capital expenditure push
Industrial credit growth slumped in July; House Price Index up 5.1% in Q1
Govt extends last date for applications under textiles PLI till Oct
India's agri growth reaps harvest of rabi at 3.5% in June quarter